drugset / Trial / NCT02769325

Atropine in Laparoscopic Gynaecological Surgery

NCT02769325

Phase 4 Unknown 150 enrolled Clinica Santa Maria
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double blinded, randomised controlled trial that will compare atropine to placebo for postoperative pain in laparoscopic gynaecological surgery

Timeline

Start
2016-05
Primary completion
2017-05
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 1 mg Intravenous
Background Ketorolac Other / unclassified 30 mg Intravenous
Background Morphine Other / unclassified 1 mg Intravenous
Background Propofol Small molecule 2 mg/kg Intravenous
Background Propofol Small molecule 3 mg/kg Intravenous
Background Rocuronium Other / unclassified 0.6 mg/kg
Background Sevoflurane Other / unclassified
Background Sugammadex Other / unclassified

Indications

No indication recorded.